MERZ AESTHETICS LAUNCHES NEW BELOTERO BALANCE® (+) WITH LIDOCAINE
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the United States launch of BELOTERO BALANCE (+), the lidocaine formulation of BELOTERO BALANCE.
MERZ AESTHETICS TO PRESENT ROBUST DATA ON XEOMIN® (incobotulinumtoxinA) AT TOXINS 2021 VIRTUAL CONFERENCE
Eight accepted abstract presentations provide key updates on Xeomin® (incobotulinumtoxinA)
MERZ AESTHETICS AND CANDELA CORPORATION LAUNCH COMMERCIAL COLLABORATION CREATING BROAD MEDICAL AESTHETICS PORTFOLIO
Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.
Merz Aesthetics to sponsor and participate in first fully virtual medical aesthetics congress AMWC Global 2020
Merz Aesthetics, a global leader in medical aesthetics, today announced the presentation of data from its medical aesthetics portfolio at the 18th edition of the Aesthetic & Anti-Aging Medicine World Congress.
MERZ AESTHETICS TO PRESENT DATA FROM MEDICAL AESTHETICS PORTFOLIO AT THE AMERICAN SOCIETY OF DERMATOLOGIC SURGERY 2020 ANNUAL MEETING
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the presentation of data from its medical aesthetics portfolio.
MERZ AESTHETICS® TAPS GWYNETH PALTROW AS THE GLOBAL FACE OF XEOMIN® (incobotulinumtoxinA)
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today a partnership with Oscar and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin® (incobotulinumtoxinA).
Merz Aesthetics Launches New Vision as World's Largest Dedicated Aesthetics Business
Merz Aesthetics is pleased to announce today the launch of the “confidence to be” branding platform following the conclusion of the company’s reorganization into three independently operating businesses.
Merz Aesthetics Appoints Karl Kokrhoun as Chief Financial Officer
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the appointment of Karl Kokrhoun as Chief Financial Officer, effective May 4, 2020.
Merz Aesthetics Appoints Samantha Kerr, Ph.D., as Chief Scientific Officer
Merz Aesthetics, the largest dedicated medical aesthetics business globally, today announced the appointment of Samantha Kerr, Ph.D., as Chief Scientific Officer, effective March 16, 2020.
Merz Forms Fully focused Global Medical Aesthetics Business: Merz Aesthetics
Merz, a global leader in the field of aesthetics and neurotoxins, today announced plans to reorganize into three independently operating businesses: medical aesthetics, therapeutics and consumer care.
Merz to Present Data Across Aesthetics Portfolio at the American Society of Dermatologic Surgery 2019 Annual Meeting
Merz, a global leader in medical aesthetics, today announced the presentation of data from its aesthetics products, including Xeomin® (incobotulinumtoxinA), Ultherapy®, and Radiesse®, at the American Society of Dermatologic Surgery 2019 Annual Meeting which is taking place in Chicago from October 24 to 27.
Merz Announces New Five-Year FDA Indication for Cellulite Treatment
Merz announced today the U.S. Food and Drug Administration (FDA) has cleared Cellfina’s® new indication statement that shows the benefits of Cellfina last for five years, an increase from the previous three-year indication.
Merz Americas CEO Bob Rhatigan Joins Distinguished Life Sciences Leaders as a PharmaVOICE 100 Award Recipient
Today Merz announced Bob Rhatigan, CEO of Merz Americas, has been named one of the top 100 most inspiring and influential life sciences leaders by PharmaVOICE magazine, a premiere health care trade publication.
NEOCUTIS® Launches New Product, New Packaging and Snags 20th InStyle Best Beauty Buy Award
Merz Americas announced three updates for NEOCUTIS including the launch of NEOCUTIS Aftercare, a post-treatment soothing cream that can enhance post-procedure outcomes; new packaging for best-selling products Lumière, Lumière Riche and Bio Serum; and the recognition from InStyle for the 20th time as a Best Beauty Buy award winner.
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Third Year in a Row
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Third Year in a Row... Merz Americas CEO Bob Rhatigan named “Top Aesthetics CEO” for the third year in a row.... Key products XEOMIN®(incobotulinumtoxinA) and Ultherapy® recognized with best-in-class awards
Merz to Present Data Across Aesthetics Portfolio at “The Aesthetic Meeting 2019” in New Orleans
Accepted abstracts provide key updates on aesthetics products, including XEOMIN® (incobotulinumtoxinA), ULTHERAPY®, RADIESSE® and CELLFINA®.
Merz Showcases Data Across Multiple Injectable and Device Products at American Academy of Dermatology Annual Meeting
Merz Americas today announced the presentation of data, including one oral presentation, from studies of its aesthetics products, including Xeomin® (incobotulinumtoxinA), Ultherapy®, Radiesse® and the Cellfina® System, at the American Academy of Dermatology (AAD) annual meeting, March 1-5, in Washington, DC.
Merz and Christie Brinkley Inspire Women to Redefine Life’s Big Moments Through New “Milestones of Me” Campaign Featuring Ultherapy®
Merz Americas is partnering with supermodel, actress and entrepreneur, Christie Brinkley, to launch a new campaign, “Milestones of Me,” which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign kicks off in honor of Christie’s 65th birthday, and inspires women to not shy away from wanting to look and feel their best as they celebrate new milestones. At nearly 65, one of the ways Christie continues to look and feel great is with Ultherapy®
Merz Encourages Women to Smash through Labels and Judgment with Disruptive New DTC Campaign for XEOMIN® (incobotulinumtoxinA)
Merz Americas announced today the launch of a new advertising campaign for XEOMIN® (incobotulinumtoxinA) called “Later Haters,” which calls for women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling guilty about their self-care routines. XEOMIN is the latest botulinum toxin type A approved by the U.S. Food and Drug Administration (FDA) to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Second Year in a Row
For the second year in a row, Merz has been recognized as the “Top Aesthetics Company” by Aesthetic Everything® and Bob Rhatigan has been named the “Top Aesthetics CEO.” As part of the annual Aesthetic and Cosmetic Medicine Awards, Merz executives and products were also recognized with 14 additional award wins – 16 total wins overall.
Merz presents key findings showcasing five-year effectiveness of cellfina® on cellulite removal and physician recognition of ultherapy® as gold standard treatment
Merz, a global leader in medical aesthetics, presented five-year follow-up data on Cellfina® System, which showed that a single treatment improved the appearance of cellulite on the thighs and buttocks for five years, building upon a previous study, which showed results lasting at least three years
Merz Names Kristina Yu-Isenberg, Ph.D., Vice President of Medical Affairs North America
Merz today announced Kristina Yu-Isenberg, Ph.D., M.P.H, R.Ph., has been named Vice President of Medical Affairs North America, effective immediately. Dr. Yu-Isenberg oversees medical affairs in North America and is located in the Merz North America headquarters in Raleigh, North Carolina.
Merz Creates Americas Region, Expands Bob Rhatigan’s Leadership Role
Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as Chief Executive Officer – Americas. Expanding on his leadership of Merz’s North American business, Mr. Rhatigan will now assume responsibility for Latin America as well and will oversee the overall commercial strategy for the newly-created Americas Region. In addition, Frank Brandt-Pollmann has been promoted to Area Vice President – Latin America...
Merz North America Promotes Alana Sine to Chief Financial Officer
Merz North America today announced the appointment of Alana Sine to Chief Financial Officer (CFO), Merz North America. Sine has served as interim CFO since March 2018.
Merz Products Recognized as Best-In-Class by NewBeauty, THE European Aesthetic Guide and InStyle Magazine
Merz announced today that Ultherapy®, Radiesse® and Cellfina® have been named the best “In-Office Treatments” by NewBeauty Magazine. In addition, Cellfina® was recognized as the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide. Neocutis® Lumière® and Lumière® Riche were named “Best Beauty Buys” by InStyle Magazine...
New National Study Reveals the Need to Educate About Tattoo Removal Options
Merz North America today announced the results of a survey, conducted by Wakefield Research, to better understand public perceptions of tattoo removal. The survey results found that more than four in five adults with (86%) and without (82%) tattoos have misconceptions about tattoo removal...
Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting
Merz North America announced today that Merz aesthetics products including Xeomin®, Cellfina®, Radiesse®, Ultherapy® and DeScribe® PFD Patch will be featured in oral and online ePoster presentations at the American Academy of Dermatology (AAD) annual meeting in San Diego, CA, taking place February 16-20, 2018...
Merz Names Terri L. Phillips, M.D., Vice President and Head of Global Medical Affairs
Merz today announced that Terri L. Phillips, M.D., F.A.A.P., has been named Vice President and Head of Global Medical Affairs, effective January 2, 2018. Dr. Phillips will oversee the global medical affairs team and will be located in the Merz North America headquarters in Raleigh, N.C...
Merz North America Announces New FDA Clearance for Describe® PFD Patch. Describe®, the first and only accessory for laser-assisted tattoo removal, is cleared for use with additional lasers and wavelengths
Merz North America announced today the DESCRIBE® PFD Patch has been cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal.
Ultherapy® Named "Best Skin Tightening Device" by The Aesthetic Guide
Merz announced today Ultherapy® has been named the "Best Skin Tightening Device" by THE Aesthetic Guide, a leading aesthetic industry publication. Ultherapy® is the only FDA- cleared, non-invasive procedure that lifts and tightens the neck, chin and brow, and improves lines and wrinkles on the chest.
Christie Brinkley Partners with Merz to Share Her Approach to Looking Timeless. Ms. Brinkley Chooses Xeomin® (incobotulinumtoxinA) and Ultherapy® to Help Her Look Her Best
MERZ NAMED THE TOP AESTHETICS COMPANY BY AESTHETIC EVERYTHING®. Merz North America CEO Bob Rhatigan named the Top Aesthetics CEO Cellfina® and Ultherapy® Also Recognized as Top Procedures
Merz North America, Inc. announced today that Merz has been recognized by Aesthetic Everything® as the Top Aesthetics Company and the winner of four other 2017 Diamond Crystal Awards, including the recognition of Cellfina® as the Top Minimally Invasive Procedure and Ultherapy® as a Top Non-Surgical Procedure in the industry.
NEOCUTIS® RECEIVES ITS 16th INSTYLE “BEST BEAUTY BUY” AWARD. Lumière® Recognized by InStyle as “Best Eye Cream”
Merz Aesthetics, a division of Merz North America, announced today that NEOCUTIS® Lumière was named an InStyle 2017 "Best Beauty Buy" award winner for "Best Eye Cream."
MERZ AESTHETICS ANNOUNCES LAUNCH OF MEDERMA® QUICK DRY OIL AND MEDERMA® SPEZIAL
Merz Aesthetics, a division of Merz North America announces the U.S. launch of Mederma® Quick Dry Oil, a unique, fast-absorbing multipurpose oil formulated without artificial dyes, colors, perfumes, parabens or mineral oils that works to help diminish the appearance of scars, stretch marks, uneven skin tone and dry skin, and Mederma® Spezial, a unique collection of cream mousses and dietary supplements formulated to promote healthy skin, hair and nails.
Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America. Patrick Urban also named Chief Commercial Officer
Merz Pharma, a global leader in aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as President and Chief Executive Officer (CEO) of Merz North America and Patrick Urban as Chief Commercial Officer
ULTHERAPY® AND CELLFINA® SYSTEM RECOGNIZED AS BEST-IN-CLASS TREATMENTS IN NEWBEAUTY’S ANNUAL BEAUTY CHOICE AWARDS
Merz Aesthetics, a division of Merz North America, announced today that Ultherapy® and the Cellfina® System have been recognized by NewBeauty readers and editors in their 2017 Beauty Choice Awards as best-in-class.
MERZ AESTHETICS CELEBRATES THE 10th ANNIVERSARY OF RADIESSE. Radiesse Marks Key Milestone with Revealing Patient Survey Results
Merz Aesthetics, a division of Merz North America (U.S. affiliate of Merz Pharma Group) announced the 10-year anniversary of the launch of their flagship brand, Radiesse . Radiesse is a volumizing filler used in more than 60 countries, and is unique in its ability to provide instant lift and stimulate the natural production of collagen with just one injection. More than 6 million syringes have been purchased by professionals worldwide over the past ten years.
MERZ AESTHETICS ANNOUNCES THREE YEAR FDA CLEARANCE FOR CELLFINA™ SYSTEM. Cellfina Earns Longest FDA Cleared Duration for a Cellulite Treatment
Merz Aesthetics, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Cellfina™ System for the long-term improvement in the appearance of cellulite on the buttocks and thighs of adult females with no loss of benefit for up to 3 years.
NEOCUTIS® Receives O, The Oprah Magazine Fall Beauty 2016 “O-WARD”. MICRO•NIGHT® RICHE Rejuvenating Balm Recognized by O, The Oprah Magazine as Best Night Treatment for Sensitive Skin
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEOCUTIS MICRO•NIGHT® RICHE Rejuvenating Balm is an O, The Oprah Magazine Fall Beauty 2016 “O-Ward” winner for being a top performer in the Night Treatment category for sensitive skin.
MERZ ACQUIRES AESTHETICS MEDICAL DEVICE COMPANY ON LIGHT SCIENCES
Merz North America announced today it has expanded its aesthetic portfolio through the acquisition of ON Light Sciences, Inc.
CELLFINA™ SYSTEM RECEIVES GOOD HOUSEKEEPING BEAUTY BREAKTHROUGH AWARD. Cellulite Treatment Named Best Body Solution
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that the Cellfina™ System has received the 2016 Good Housekeeping Best of Beauty Awards in the Body Solution category. Cellfina™ is the only FDA-cleared minimally invasive procedure clinically proven to improve the appearance of cellulite in the buttocks and thighs of adult females, for results that last at least two years, the longest duration cleared by the FDA. Winners are featured in the May 2016 issue of Good Housekeeping Magazine.
NEOCUTIS® RECEIVES ITS 15th InStyle ”BEST BEAUTY BUY” AWARD. Lumière® and Lumière Riche Recognized by InStyle as Best Eye Treatments
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEOCUTIS® Lumière and Lumière Riche were named InStyle 2016 “Best Beauty Buys” award winners for Best Eye Treatment and Best Eye Treatment for Dry Skin, respectively.
CELLFINA™ SYSTEM LAUNCHES NATIONWIDE AT THE AMERICAN SOCIETY FOR AESTHETIC PLASTIC SURGERY. Data on New Treatment Also Being Presented At Annual Meeting
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that its Cellfina™ System will launch nationwide at the Annual Meeting for the American Society for Aesthetic Plastic Surgery in Las Vegas, NV. Cellfina is the only FDA-cleared, minimally invasive procedure clinically proven to improve the appearance of cellulite for results that last at least two years – the longest duration cleared by the FDA.
ULTHERAPY® AWARDED “BEST NONSURGICAL SKIN TIGHTENER” IN NEWBEAUTY’S ANNUAL BEAUTY CHOICE AWARDS. Ultherapy® Earns a Best of Beauty Award for the Third Year in a Row
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that Ultherapy® has been named “Best Nonsurgical Skin Tightener” in the 2016 Beauty Choice Awards.
NEOCUTIS® LAUNCHES MICRO•FIRM™ NECK & DÉCOLLETÉ REJUVENATING COMPLEX POWERED BY MPC™
Merz Aesthetics Skincare, a division of Merz North America (U.S. affiliate of Merz Pharma Group) today announced the launch of its newest skincare product, MICRO•FIRM™ NECK & DÉCOLLETÉ Rejuvenating Complex by NEOCUTIS®. This advancement in anti-aging skincare was developed to help revitalize skin and improve the appearance of aging on the neck and décolleté. Formulated with Micro Protein Complex (MPC™), this unique peptide blend is the first anti-aging technology to help rejuvenate skin’s elasticity.
MERZ AESTHETICS ANNOUNCES TWO LATE-BREAKING RESEARCH FORUM PRESENTATIONS AT THE AMERICAN ACADEMY OF DERMATOLOGY MEETING. Abstracts Highlight Ground-Breaking Updates at the Annual Meeting
MERZ AESTHETICS ANNOUNCES KEY DATA PRESENTATIONS AT THE AMERICAN ACADEMY OF DERMATOLOGY MEETING. Data highlights overall commitment to continued development in aesthetics
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group) announced today that it will be presenting 13 posters at the annual American Academy of Dermatology Meeting this weekend in Washington D.C.